Literature DB >> 2873216

The effect of temperature on the plasto-elasticity of some pharmaceutical powders and on the tensile strengths of their tablets.

S Esezobo, N Pilpel.   

Abstract

Measurements have been made of the stress relaxation (SR) during, and of the elastic recovery (ER) after, compression of four directly compressible excipients, and of chloroquine diphosphate and of a paracetamol tablet formulation at temperatures between -10 and +65 degrees C and of the tensile strengths of the tablets produced. It was found that at a fixed packing fraction, the stress relaxation and tensile strength of all the materials increased and the ratio ER/SR decreased as the compression temperature was raised. Tensile strength was inversely proportional to ER/SR at all the temperatures studied. Values for the activation energies (Eo) of bonding between particles for all the materials were derived from plots of the log of tensile strength and of log SR/ER versus the reciprocal of the absolute temperature. The values of Eo obtained from the latter plots tended to be higher than from the former by a factor of between 1.5 and 4.5.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873216     DOI: 10.1111/j.2042-7158.1986.tb04602.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

Review 1.  Principles and application of ultrasound in pharmaceutical powder compression.

Authors:  M Levina; M H Rubinstein; A R Rajabi-Siahboomi
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

2.  A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting.

Authors:  Frederick Osei-Yeboah; Shao-Yu Chang; Changquan Calvin Sun
Journal:  Pharm Res       Date:  2016-01-14       Impact factor: 4.200

3.  Thermophysical properties of some pharmaceutical excipients compressed in tablets.

Authors:  J Ketolainen; L Kubicár; V Bohác; M Markovic; P Paronen
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.